FINANCIALS

LUMO Lumos Pharma Inc 1126234

Income Statement
Revenue	nlnk-20240930	726,000
Net Income	nlnk-20240930	-7,467,000
Profit Margin		-1028.51%

Balance Sheet
Current Assets	17,274,000
Assets	17,461,000
Current Liabilities	6,505,000
Liabilities	12,547,000
Equity	4,914,000
Shares Out	8,124,000

Cash Flow Statement
Operating Cash Flow	-24,280,000
Investing Cash Flow	1,000,000

Market Analysis
Market Cap	31,358,785
BVPS	0.60
PB	0.52
EPS	-4.43
PS	10.80
FCF	-23,280,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view LUMO documents filed with the SEC.

LUMO Filings Clear

View A List of Tickers